BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23797698)

  • 21. A prospective evaluation of serum methionine-related metabolites in relation to pancreatic cancer risk in two prospective cohort studies.
    Huang JY; Luu HN; Butler LM; Midttun Ø; Ulvik A; Wang R; Jin A; Gao YT; Tan Y; Ueland PM; Koh WP; Yuan JM
    Int J Cancer; 2020 Oct; 147(7):1917-1927. PubMed ID: 32222976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maternal betaine status, but not that of choline or methionine, is inversely associated with infant birth weight.
    Du YF; Wei Y; Yang J; Cheng ZY; Zuo XF; Wu TC; Shi HF; Wang XL
    Br J Nutr; 2019 Jun; 121(11):1279-1286. PubMed ID: 30837009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preclinical Evaluation of
    Piert M; Shao X; Raffel D; Davenport MS; Montgomery J; Kunju LP; Hockley BG; Siddiqui J; Scott PJH; Chinnaiyan AM; Rajendiran T
    J Nucl Med; 2017 Aug; 58(8):1216-1223. PubMed ID: 28302759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Choline degradation in
    Parekh T; Tsai M; Spiro S
    J Bacteriol; 2024 Apr; 206(4):e0008124. PubMed ID: 38501746
    [No Abstract]   [Full Text] [Related]  

  • 25. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
    Gann PH; Ma J; Giovannucci E; Willett W; Sacks FM; Hennekens CH; Stampfer MJ
    Cancer Res; 1999 Mar; 59(6):1225-30. PubMed ID: 10096552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relation of exposure to amino acids involved in sarcosine metabolic pathway on behavior of non-tumor and malignant prostatic cell lines.
    Heger Z; Gumulec J; Cernei N; Polanska H; Raudenska M; Masarik M; Eckschlager T; Stiborova M; Adam V; Kizek R
    Prostate; 2016 May; 76(7):679-90. PubMed ID: 26847870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence of choline depletion and reduced betaine and dimethylglycine with increased homocysteine in plasma of children with cystic fibrosis.
    Innis SM; Hasman D
    J Nutr; 2006 Aug; 136(8):2226-31. PubMed ID: 16857845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma choline, nicotine exposure, and risk of low bone mineral density and hip fracture: the Hordaland health study.
    Øyen J; Nygård OK; Gjesdal CG; Ueland PM; Apalset EM; Schartum-Hansen H; Vollset SE; Meyer K; Tell GS
    J Bone Miner Res; 2014 Jan; 29(1):242-50. PubMed ID: 23794246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maternal choline intake modulates maternal and fetal biomarkers of choline metabolism in humans.
    Yan J; Jiang X; West AA; Perry CA; Malysheva OV; Devapatla S; Pressman E; Vermeylen F; Stabler SP; Allen RH; Caudill MA
    Am J Clin Nutr; 2012 May; 95(5):1060-71. PubMed ID: 22418088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association of betaine, homocysteine and related metabolites with cognitive function in Dutch elderly people.
    Eussen SJ; Ueland PM; Clarke R; Blom HJ; Hoefnagels WH; van Staveren WA; de Groot LC
    Br J Nutr; 2007 Nov; 98(5):960-8. PubMed ID: 17537289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma isoflavones and subsequent risk of prostate cancer in a nested case-control study: the Japan Public Health Center.
    Kurahashi N; Iwasaki M; Inoue M; Sasazuki S; Tsugane S
    J Clin Oncol; 2008 Dec; 26(36):5923-9. PubMed ID: 19018085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obesity, adipokines, and prostate cancer in a prospective population-based study.
    Baillargeon J; Platz EA; Rose DP; Pollock BH; Ankerst DP; Haffner S; Higgins B; Lokshin A; Troyer D; Hernandez J; Lynch S; Leach RJ; Thompson IM
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1331-5. PubMed ID: 16835332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Choline and betaine intake and colorectal cancer risk in Chinese population: a case-control study.
    Lu MS; Fang YJ; Pan ZZ; Zhong X; Zheng MC; Chen YM; Zhang CX
    PLoS One; 2015; 10(3):e0118661. PubMed ID: 25785727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gut Microbiome-Dependent Metabolic Pathways and Risk of Lethal Prostate Cancer: Prospective Analysis of a PLCO Cancer Screening Trial Cohort.
    Reichard CA; Naelitz BD; Wang Z; Jia X; Li J; Stampfer MJ; Klein EA; Hazen SL; Sharifi N
    Cancer Epidemiol Biomarkers Prev; 2022 Jan; 31(1):192-199. PubMed ID: 34711629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Peters U; Leitzmann MF; Chatterjee N; Wang Y; Albanes D; Gelmann EP; Friesen MD; Riboli E; Hayes RB
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):962-8. PubMed ID: 17507623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An isotope dilution capillary electrophoresis/tandem mass spectrometry (CE-MS/MS) method for the simultaneous measurement of choline, betaine, and dimethylglycine concentrations in human plasma.
    Forteschi M; Zinellu A; Assaretti S; Mangoni AA; Pintus G; Carru C; Sotgia S
    Anal Bioanal Chem; 2016 Oct; 408(26):7505-12. PubMed ID: 27503542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediagnostic Serum Organochlorine Concentrations and Metastatic Prostate Cancer: A Nested Case-Control Study in the Norwegian Janus Serum Bank Cohort.
    Koutros S; Langseth H; Grimsrud TK; Barr DB; Vermeulen R; Portengen L; Wacholder S; Freeman LE; Blair A; Hayes RB; Rothman N; Engel LS
    Environ Health Perspect; 2015 Sep; 123(9):867-72. PubMed ID: 25734605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simple method for the routine determination of betaine and N,N-dimethylglycine in blood and urine.
    Laryea MD; Steinhagen F; Pawliczek S; Wendel U
    Clin Chem; 1998 Sep; 44(9):1937-41. PubMed ID: 9732980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarkers related to one-carbon metabolism as potential risk factors for distal colorectal adenomas.
    de Vogel S; Schneede J; Ueland PM; Vollset SE; Meyer K; Fredriksen A; Midttun Ø; Bjørge T; Kampman E; Bretthauer M; Hoff G
    Cancer Epidemiol Biomarkers Prev; 2011 Aug; 20(8):1726-35. PubMed ID: 21693628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study.
    Stattin P; Lumme S; Tenkanen L; Alfthan H; Jellum E; Hallmans G; Thoresen S; Hakulinen T; Luostarinen T; Lehtinen M; Dillner J; Stenman UH; Hakama M
    Int J Cancer; 2004 Jan; 108(3):418-24. PubMed ID: 14648709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.